General Information of Drug Inactive Ingredient (DIG) (ID: E00354)

DIG Name
Diazolidinyl urea
Synonyms
DIAZOLIDINYL UREA; Diazolidinylurea; 78491-02-8; 1-(1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea; N,N'-Bis(hydroxymethyl) urea; 1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea; N-(1,3-Bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N'-bis(hydroxymethyl)urea; n-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-n,n'-bis(hydroxymethyl)urea; Urea, N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N'-bis(hydroxymethyl)-; Diazolidinyl urea, 95%; DSSTox_CID_9559; DSSTox_RID_78776; DSSTox_GSID_29559; Germall 11; Imidazolidinyl urea 11; Urea, N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N'-bis(hydroxymethyl)-; N-[1,3-bis(hydroxymethyl)-2,5-dioxo(1,3-diazolidin-4-yl)]-N-(hydroxymethyl)[(h ydroxymethyl)amino]carboxamide; CAS-78491-02-8; EINECS 278-928-2; EC 278-928-2; Diazolidinyl urea, >=95%; N-(Hydroxymethyl)-N-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl)-N'-(hydroxymethyl) urea; N-(Hydroxymethyl)-N-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl)-N'-(hydroxymethyl)urea; SCHEMBL34370; CHEMBL3187032; DTXSID0029559; N-(1,3-Bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-; CHEBI:136014; Tox21_202068; Tox21_303365; s5292; SBB003028; AKOS016010254; CCG-267223; CS-W010066; DB14173; MCULE-9508067464; Urea, N-(1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl-N,N'-bis(hyd- roxymethyl)-; NCGC00249159-01; NCGC00257237-01; NCGC00259617-01; AS-73729; O201; ST056226; SY033470; DB-056316; D3769; FT-0641680; Q5272201; W-104279; 1,3-Bis(hydroxymethyl)-5-[1,3-bis(hydroxymethyl)ureido]hydantoin; N-[1,3-Bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N inverted exclamation mark -bis(hydroxymethyl)urea
DIG Function
Antimicrobial preservative
Formula
C8H14N4O7
Canonical SMILES
C(NC(=O)N(CO)C1C(=O)N(C(=O)N1CO)CO)O
InChI
1S/C8H14N4O7/c13-1-9-7(18)10(2-14)5-6(17)12(4-16)8(19)11(5)3-15/h5,13-16H,1-4H2,(H,9,18)
InChIKey
SOROIESOUPGGFO-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 278.22 Topological Polar Surface Area 154
XlogP -2.5 Complexity 376
Heavy Atom Count 19 Rotatable Bond Count 5
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 7

Full List of Drug(s) Co-administrated with This DIG

2 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Calcipotriol DM03CP7 Psoriasis [EA90] Calcipotriene 0.005% ointment F23660
Tetracaine DM9J6C2 Spinal anesthesia [MB40.3] Tetracaine 1% cream F23306
------------------